Medications for CDKL5 Deficiency Disorder
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in CDKL5 Deficiency Disorder.
Found 1 Approved Drug for CDKL5 Deficiency Disorder
Ztalmy
Generic Name
Ganaxolone
Ztalmy
Generic Name
Ganaxolone
Form: Suspension
Method of administration: Oral
FDA approval date: June 06, 2022
Classification: Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator
ZTALMY is indicated for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older. ZTALMY is a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator indicated for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances